stella
beta
Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous Nephropathy — Stella
Home
/
Primary Membranous Nephropathy
/
View on ClinicalTrials.gov
Recruiting
Back to Primary Membranous Nephropathy trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
General hospital of eastern theater command, Nanjing, Jiangsu